In an era where speed and precision define success in pharmaceutical innovation, designing efficient clinical development strategies is critical—especially for early-stage products. In this session, Dr. Mukesh, a seasoned expert in clinical research, will share actionable insights into building lean, effective development pathways that balance scientific rigor with regulatory readiness. The talk will delve into optimizing protocol design including translational bio markers, leveraging early-phase data for strategic decision-making, and navigating regulatory landscapes to accelerate time-to-market—helping pharma innovators reduce attrition and unlock value earlier in the development cycle.